Streamex Corp. (STEX) Stock

Streamex Corp. (STEX) is a Healthcare stock trading at $0.82 (as of 2026-08-20), with a market capitalization of $85.66M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.

Understand Streamex Corp.: how it makes money

Streamex Corp. provides institutional-grade infrastructure to tokenize real-world assets, with a focus on gold- and commodities-backed tokenization using blockchain technology, powered by a gold-denominated treasury.

Profitability is driven by scaling tokenized asset activity tied to its gold- and commodities-backed infrastructure, especially gold-denominated assets under management and related distributions accessed through its tokenization platform.

Business quality (Weak): The business has a clear thematic profit engine around tokenizing gold- and commodities-backed real-world assets, but the latest reported quarter shows very large operating losses, and the company has recently rebranded and changed its focus following a merger.

Bull case

  • Gold and commodities tokenization focus: Streamex shifted focus toward real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology.
  • Institutional-grade tokenization infrastructure: The company provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.
  • Operating activity metrics exist to track: Its operational KPIs include Gold with Yield Assets Under Management (count 3096.6) and Gold with Yield Dividends Distributed (count 10.48), which can help investors monitor platform engagement.

Bear case

  • Very large operating loss in the latest reported quarter: For the period ended 2024-09-30, operating_margin_pct is -10925.9, indicating significant operating losses (revenue_b is reported as 0.0 in the provided data).
  • Recent rebrand and focus shift adds execution risk: BioSig Technologies, Inc. rebranded to Streamex Corp. effective September 12, 2025 after its merger, and the company shifted focus from healthcare technology to real-world asset tokenization.
  • Dependence on gold and retirement-related tokenization activity: The operational KPIs provided center on gold with yield and U.S. tax-advantaged retirement capital accessed via equity trust, which could concentrate performance sensitivity in these areas.
Valuation — source: SEC EDGAR (first-party)
Price$0.82
Market Cap$85.66M
Price / Book0.58
Price / Sales432.64
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$40000.00
Net Margin-25825.0%
Revenue Growth (YoY)122.2%
EPS Growth (YoY)-81.0%
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderLegacy Wealth Managment, LLC/ID ($7.94M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOKarl Henry McPhie
Employees5
CountryUS
IPO Date2025-09-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Stereotaxis, Inc. (STXS)
  • FONAR Corporation (FONR)
  • Vivani Medical, Inc. (VANI)
  • electroCore, Inc. (ECOR)
  • Hyperfine, Inc. (HYPR)
  • Outset Medical, Inc. (OM)
  • NeurAxis, Inc. (NRXS)
  • Precision Optics Corporation, Inc. (POCI)
STEX earnings history · STEX institutional & insider holders · STEX KPIs & operating metrics · STEX financials · STEX investor presentations & press releases · STEX SEC filings · STEX peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.